$3.50
-0.27-7.16%
Last update: Oct 16, 7:02 PM
$3.45
-0.32-8.49%
Ironwood Pharmaceuticals Inc
IRWDNASDAQ
Ironwood Pharmaceuticals (IRWD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ironwood Pharmaceuticals (IRWD) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $460M - $485M for the period.
Compared to prior guidance, Ironwood Pharmaceuticals raised its revenue forecast from a prior range of $450M - $475M.
Ironwood Pharmaceuticals has issued 22 guidance updates between November 3, 2022 and August 6, 2026. During this period, the company raised its outlook 5 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.27 | $0.21 | $0.01 | $0.11 |
| Actual | $0.31 | $0.24 | $-0.01 | $0.24 |
| Surprise | +14.8% | +14.3% | -200.0% | +118.2% |
| Revenue | ||||
| Estimate | $118.0M | $88.4M | $51.7M | $72.8M |
| Actual | $113.0M | $106.5M | $47.7M | $122.1M |
| Surprise | -4.24% | +20.4% | -7.68% | +67.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.31 | $0.32 | $0.03 | $0.03 |
| Revenue | ||||
| Consensus | $127.1M | $122.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.31 | $0.27 | 14.8 % |
| Q1 | May 7, 2026 | $0.24 | $0.21 | 14.3 % |
| Q4 | Feb 25, 2026 | $-0.01 | $0.01 | -200.0 % |
| Q3 | Nov 10, 2025 | $0.24 | $0.11 | 118.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $113.04M | $118.04M | -4.24 % |
| Q1 | May 7, 2026 | $106.51M | $88.45M | 20.4 % |
| Q4 | Feb 25, 2026 | $47.71M | $51.68M | -7.68 % |
| Q3 | Nov 10, 2025 | $122.06M | $72.81M | 67.6 % |
